Chrysanthi Vadikolia

Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group

Eirini Katodritou, Evangelos Terpos, Sossana Delimpasi et al. · Blood Cancer Journal · 2018 · 46 citations · Full text

“Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group

Eirini Katodritou, Chrysanthi Vadikolia, Chrysavgi Lalagianni et al. · Annals of Hematology · 2013 · 39 citations

Hematological Malignancy, Medicine, Hematology +6

Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Cell Transplantation

Ioanna Sakellari, Despina Mallouri, Eleni Gavriilaki et al. · Biology of Blood and Marrow Transplantation · 2016 · 36 citations

Central nervous system multiple myeloma: A real‐world multi‐institutional study of the Greek Myeloma Study Group

Eirini Katodritou, Dimitra Dalampira, Sosana Delimpasi et al. · American Journal of Hematology · 2024 · 15 citations · Full text